CN111253477B - 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 - Google Patents
猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 Download PDFInfo
- Publication number
- CN111253477B CN111253477B CN202010155302.1A CN202010155302A CN111253477B CN 111253477 B CN111253477 B CN 111253477B CN 202010155302 A CN202010155302 A CN 202010155302A CN 111253477 B CN111253477 B CN 111253477B
- Authority
- CN
- China
- Prior art keywords
- porcine circovirus
- protein
- circovirus type
- virus
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010155302.1A CN111253477B (zh) | 2020-03-10 | 2020-03-10 | 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010155302.1A CN111253477B (zh) | 2020-03-10 | 2020-03-10 | 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111253477A CN111253477A (zh) | 2020-06-09 |
CN111253477B true CN111253477B (zh) | 2022-05-31 |
Family
ID=70953001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010155302.1A Active CN111253477B (zh) | 2020-03-10 | 2020-03-10 | 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111253477B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112501186B (zh) * | 2020-11-26 | 2023-04-07 | 浙江鼎持生物制品有限公司 | 猪圆环病毒2d型CAP蛋白及其在亚单位疫苗制备中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3362467A4 (en) * | 2015-10-16 | 2019-06-12 | Kansas State University Research Foundation | IMMUNOGENIC COMPOSITIONS AGAINST PORCINIC CIRCOVIRUS TYPE 3 AND METHODS OF MAKING AND USING SAME |
CN108159409A (zh) * | 2017-12-25 | 2018-06-15 | 南京大爻网络科技有限公司 | 一种猪圆环病毒3型Cap蛋白疫苗及其制备方法和应用 |
CN108611359B (zh) * | 2018-05-04 | 2021-11-19 | 武汉科前生物股份有限公司 | 猪圆环病毒3型病毒样颗粒的制备方法及其应用 |
CN109852622B (zh) * | 2019-01-18 | 2022-05-27 | 南京农业大学 | 一种可溶性PCV3Cap蛋白及其编码基因和应用 |
CN110204598B (zh) * | 2019-06-14 | 2021-02-26 | 军事科学院军事医学研究院军事兽医研究所 | 一种猪圆环病毒ⅲ型病毒样颗粒及其制备方法 |
CN110684084A (zh) * | 2019-10-25 | 2020-01-14 | 天津瑞普生物技术股份有限公司 | 一种猪圆环病毒3型(PCV-3)Cap蛋白病毒样颗粒的制备方法及应用 |
-
2020
- 2020-03-10 CN CN202010155302.1A patent/CN111253477B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111253477A (zh) | 2020-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9782471B2 (en) | EV71 virus-like particles and preparation method and application thereof | |
CN111234036B (zh) | 非洲猪瘟病毒p72融合蛋白及其制备方法和应用 | |
KR102640490B1 (ko) | 키메라 유두종바이러스 l1 단백질 | |
NL2025015B1 (en) | Method for Efficiently Expressing PCV2 Cap and PCV3 Cap Fusion Protein | |
CN113845576A (zh) | 重组猫疱疹病毒1型gB-gD蛋白及其应用 | |
CN111875676A (zh) | 非洲猪瘟病毒免疫原的p49突变蛋白、重组载体、大肠杆菌基因工程菌及制备方法和应用 | |
CN111253477B (zh) | 猪圆环病毒3型Cap蛋白、核酸、病毒样颗粒、疫苗及制备方法和应用 | |
CN112280792B (zh) | 人乳头瘤病毒基因,及载体,菌株,表达方法 | |
CN110129348A (zh) | 高效制备口蹄疫病毒样颗粒的重组dna载体、应用和疫苗 | |
CN102586287A (zh) | 一种hpv16l1多核苷酸序列及其表达载体、宿主细胞和应用 | |
CN110684084A (zh) | 一种猪圆环病毒3型(PCV-3)Cap蛋白病毒样颗粒的制备方法及应用 | |
CN111349621B (zh) | 一种重组杆状病毒及其在制备新城疫病毒样颗粒中的应用 | |
CN113549634B (zh) | 编码可溶性hpv58 l1蛋白的基因及其重组质粒的构建与应用 | |
CN104845985B (zh) | 重组人乳头瘤病毒蛋白表达 | |
CN101942496B (zh) | 一种神经坏死病毒的病毒类似物的制备方法 | |
CN114058524A (zh) | 一种法氏囊亚病毒颗粒疫苗及其制备方法 | |
CN103215302B (zh) | 用汉逊酵母表达系统产生hpv18 l1蛋白的方法 | |
CN113735943A (zh) | 一种重组的非洲猪瘟病毒p72亚单位蛋白和制备方法及其应用 | |
CN113336858A (zh) | 单一位点嵌合巴氏杆菌PlpE抗原表位的兔出血症病毒VP60重组抗原及其制备和应用 | |
CN103361280B (zh) | 用汉逊酵母表达系统产生hpv11 l1蛋白的方法 | |
CN106986943B (zh) | 一种包含北极地松鼠肝炎病毒核心蛋白的重组融合蛋白及其制备方法和应用 | |
CN102234661A (zh) | 人乳头瘤病毒类病毒颗粒的制备方法和外源蛋白表达盒、表达系统 | |
CN111575315A (zh) | 一种兔病毒性出血症病毒ⅱ型vlp疫苗 | |
CN109750050B (zh) | 重组人乳头瘤病毒45亚型蛋白表达 | |
CN117417441B (zh) | 一条抗新城疫病毒的重组纳米抗体及其表达工程菌株和制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant after: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Applicant after: TECON BIOLOGICAL Co.,Ltd. Address before: 2-3 / F, building 8, 338 Galileo Road, Shanghai pilot Free Trade Zone, 201210 Applicant before: Tiankang Biology (Shanghai) Co.,Ltd. Applicant before: TECON BIOLOGICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220412 Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant after: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Address before: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Applicant before: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. Applicant before: TECON BIOLOGICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Patentee after: Tiankang Pharmaceutical Co.,Ltd. Address before: 215000 station 6-013, 6 / F, No. 88, modern Avenue, Suzhou Industrial Park, Suzhou area, China (Jiangsu) pilot Free Trade Zone, Suzhou, Jiangsu (cluster registration) Patentee before: Tiankang Pharmaceutical (Suzhou) Co.,Ltd. |